For instance, liraglutide (Victoza), dulaglutide (Trulicity), and subcutaneous semaglutide (Ozempic) have data supporting risk reduction of major adverse cardiovascular events as well as preserving kidney function in patients with T2DM.(2)(3)(4) Another benefit of GLP-1 and GIP/GLP-1 receptor agonists is significant weight loss, specifically seen with liraglutide, semaglutide, and tirzepatide, which are now available as FDA approved products for weight management with the brand names Saxenda, Wegovy, and Zepbond respectively.(5)(6)(7) While these products have great glycemic, weight, and cardiovascular outcomes, the benefits have resulted in some detrimental repercussions
Before you consider stopping your medication, work with your healthcare team to ensure your new eating patterns feel sustainable without chemical appetite suppression
The availability of compounded semaglutide may be affected over time as regulations evolve
"The nice thing about tablets is that virtually everyone is used to taking a tablet for something, even if it's just a vitamin
Participants lost an average of 11.5% of body weight after just 26 weeks
Supporting healthy blood sugar levels